Concurrent Vibrio cholerae O1 Meningitis and Intracranial Lesions in a Patient With Sickle Cell Disease: A Case Report. [PDF]
Alshuaibi TA +4 more
europepmc +1 more source
Human antibody targeting <i>Vibrio cholerae</i> O1 O-specific polysaccharide induces an amotile hypovirulent bacterial phenotype: mechanism of protection against cholera. [PDF]
Verma S +23 more
europepmc +1 more source
Environmental prevalence of toxigenic Vibrio cholerae O1 in Bangladesh coincides with V. cholerae non-O1 non-O139 genetic variants which overproduce autoinducer-2. [PDF]
Naser IB +5 more
europepmc +1 more source
New medium for the production of cholera toxin by Vibrio cholerae O1 biotype El Tor
E. Tor, M. Iwanaga, Koichiro Yamamoto
semanticscholar +1 more source
Vibriocidal efficacy of Bifidobacterium bifidum and Lactobacillus acidophilus cell-free supernatants encapsulated in chitosan nanoparticles against multi-drug resistant Vibrio cholerae O1 El Tor. [PDF]
Derakhshan-Sefidi M +2 more
europepmc +1 more source
Genomic analysis of Vibrio cholerae O1 isolates from cholera cases, Europe, 2022. [PDF]
Rouard C +21 more
europepmc +1 more source
Outbreak of <i>Vibrio cholerae</i>, Mayotte, France, April to July 2024. [PDF]
Mazzilli S +14 more
europepmc +1 more source
Erratum to: Use of a MAIT-Activating Ligand, 5-OP-RU, as a Mucosal Adjuvant in a Murine Model of Vibrio cholerae O1 Vaccination. [PDF]
Jensen O +7 more
europepmc +1 more source

